| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/02/2011 | US7989182 Nucleic acid encoding SCN1A variant |
| 08/02/2011 | US7989165 Tape stripping methods for analysis of skin disease and pathological skin state |
| 08/02/2011 | US7989162 Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 08/02/2011 | US7988980 Tuberculosis vaccine with improved efficacy |
| 08/02/2011 | US7988979 Neisseria meningitidis antigens and compositions |
| 08/02/2011 | US7988975 Modified HIV-1 group M cyclic gp41 peptides and their use in the detection of anti-HIV-1 antibodies |
| 08/02/2011 | US7988974 comprise a macromolecular carrier group fused to a gp41-derived DP178 peptide corresponding to amino acids 638 to 673 of the HIV-1LA1 gp41 protein; inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells |
| 08/02/2011 | US7988972 Immunoreactive peptides from Epstein-Barr virus |
| 08/02/2011 | US7988969 Treatment for central nervous system disorders |
| 08/02/2011 | US7988964 NOGO-a neutralising immunoglobulin for treatment of neurological diseases |
| 08/02/2011 | US7988959 Method of treatment using organotypically cultured skin tissue comprising niks cells that express exogenous HIF-1a |
| 08/02/2011 | CA2650546C Use of selected lactic acid bacteria for reducing infantile colic |
| 08/02/2011 | CA2505067C Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 08/02/2011 | CA2450318C Improved methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms |
| 08/02/2011 | CA2449634C Somatostatin-dopamine chimeric analogs |
| 08/02/2011 | CA2447632C Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor |
| 08/02/2011 | CA2441690C Method for the identification of antigenic peptides |
| 08/02/2011 | CA2436623C Branched polyalkylene glycols |
| 08/02/2011 | CA2412650C Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 08/02/2011 | CA2407309C Dna sequences encoding dystrophin minigenes and methods of use thereof |
| 08/02/2011 | CA2349038C Methods of alleviating cancer symptoms |
| 08/02/2011 | CA2329683C Iga nephropathy-related dna |
| 08/02/2011 | CA2320220C Isolated dna or gene responsible for parkinson's disease |
| 08/02/2011 | CA2282300C Recombinant pox virus for immunization against muc1 tumor-associated antigen |
| 08/02/2011 | CA2219275C Therapeutic agent and treatment for canine intractable dermatitis |
| 08/02/2011 | CA2107569C Parathyroid hormone receptor and dna encoding same |
| 08/02/2011 | CA1341619C Recombinant inhibin |
| 07/28/2011 | WO2011091419A2 Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery |
| 07/28/2011 | WO2011091376A2 Immunogenic influenza composition |
| 07/28/2011 | WO2011091370A1 Methods of intracellular conversion of single-chain proteins into their di-chain form |
| 07/28/2011 | WO2011091350A2 Methods & compositions for improving protein production |
| 07/28/2011 | WO2011090973A2 Immunotherapy compositions and methods of treatment |
| 07/28/2011 | WO2011090712A2 Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions |
| 07/28/2011 | WO2011090684A2 Methods for developing endothelial cells from pluripotent cells and endothelial cells derived |
| 07/28/2011 | WO2011090272A2 OsMPT GENE MODIFYING PLANT ARCHITECTURE (PLANT SHAPE) AND INCREASING YIELD, AND USE THEREOF |
| 07/28/2011 | WO2011090065A1 Peptide vaccine |
| 07/28/2011 | WO2011089903A1 A method for immobilizing protein a on a self-assembled monolayer |
| 07/28/2011 | WO2011089541A1 Methods for intracellular delivery of nucleic acids |
| 07/28/2011 | WO2011089288A1 Composition comprising gdnf and tgf-β1 and use thereof for the treatment of a neurological disease |
| 07/28/2011 | WO2011089170A2 Process for preparing fgf-21 with low degree of o-glycosylation |
| 07/28/2011 | WO2011069164A3 Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof |
| 07/28/2011 | WO2011058029A9 Plants having enhanced yield-related traits and a method for making the same |
| 07/28/2011 | WO2011038133A3 Umbilical cord lining stem cells and methods and material for isolating and culturing same |
| 07/28/2011 | WO2011038061A3 Novel npr-b agonists |
| 07/28/2011 | WO2011036450A3 Splice variants |
| 07/28/2011 | WO2011004263A9 Conserved escherichia coli immunogens |
| 07/28/2011 | WO2011003085A9 Hyr1 as a target for active and passive immunization against candida |
| 07/28/2011 | US20110185452 Compositions and methods for improving plants |
| 07/28/2011 | US20110185449 Modified Xylan Production |
| 07/28/2011 | US20110185444 Polynucleotide and polypeptide sequences associated with herbicide tolerance |
| 07/28/2011 | US20110185439 G protein coupled receptors and uses thereof |
| 07/28/2011 | US20110184375 Marker sequence for neurodegenerative diseases and the use thereof |
| 07/28/2011 | US20110184153 Modified gherlin peptides |
| 07/28/2011 | US20110184149 Preparation of canola protein isolate from canola oil seeds ("blendertein") |
| 07/28/2011 | US20110184146 Antioxidant polypeptide and a process for isolation and purification of the same |
| 07/28/2011 | US20110183923 Peptide antagonists of zonulin and methods for use of the same |
| 07/28/2011 | US20110183922 Peptides that enhance acetylcholinesterase expression |
| 07/28/2011 | US20110183921 Peptides capable of modulating the function of tirc7 |
| 07/28/2011 | US20110183920 Modified il-4 mutein receptor antagonists |
| 07/28/2011 | US20110183917 P53 Activator Peptides |
| 07/28/2011 | US20110183916 Apo-2 Ligand |
| 07/28/2011 | US20110183911 Method for improving neurotransmission failure using a novel agent |
| 07/28/2011 | US20110183909 Treatment of Mood and Anxiety Disorders |
| 07/28/2011 | US20110183907 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
| 07/28/2011 | US20110183906 Factor ix conjugates with extended half-lives |
| 07/28/2011 | US20110183902 Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition |
| 07/28/2011 | US20110183896 Enhancement of bacillus thuringiensis cry protein toxicities to coleopterans, and novel insect cadherin fragments |
| 07/28/2011 | US20110183893 Non-natural mic proteins |
| 07/28/2011 | US20110183891 Methods and Compositions for Inhibiting Fungal Infection and Disease |
| 07/28/2011 | US20110183885 Neo-tryptophan |
| 07/28/2011 | US20110183863 Protein screening methods |
| 07/28/2011 | US20110183861 Methods to stabilize proteins and polypeptides |
| 07/28/2011 | US20110183860 Protein Aggregation Domains and Methods of Use Thereof |
| 07/28/2011 | US20110183855 Somatic hypermutation systems |
| 07/28/2011 | US20110183425 Protein Complexes and Screening Methods |
| 07/28/2011 | US20110183418 Peptide-Polymer Cell Culture Articles and Methods of Making |
| 07/28/2011 | US20110183412 Alteration of fc-fusion protein serum half-lives by mutagenesis |
| 07/28/2011 | US20110183399 Maize Cellulose Synthases and Uses Thereof |
| 07/28/2011 | US20110183374 Thiopeptide precursor protein, gene encoding it and uses thereof |
| 07/28/2011 | US20110183362 Compositions and methods for measuring levels of bioactive human hepcidin |
| 07/28/2011 | US20110183359 Methods for detecting modulators of cytokine receptor zalpha11 |
| 07/28/2011 | US20110183354 HUMAN Fc GAMMA RECEPTOR III |
| 07/28/2011 | US20110183329 Protein phosphatase-1 inhibitor-1 polymorphism and methods of use |
| 07/28/2011 | US20110183324 Tumor suppressor gene p33ing2 |
| 07/28/2011 | US20110183021 Compositions Containing Purine Nucleosides and Manganese and Their Uses |
| 07/28/2011 | US20110183008 Lactoferrin |
| 07/28/2011 | US20110182981 Gonococcal vaccines |
| 07/28/2011 | US20110182974 Multimeric multiepitope influenza vaccines |
| 07/28/2011 | US20110182940 Method for producing purified influenza virus antigen |
| 07/28/2011 | US20110182936 Influenza hemagglutinin and neuraminidase variants |
| 07/28/2011 | US20110182933 Modified vaccinia ankara virus variant |
| 07/28/2011 | US20110182932 Modified vaccinia ankara virus variant |
| 07/28/2011 | US20110182929 Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia |
| 07/28/2011 | US20110182927 Inhibitors of DNA Immunostimulatory Sequence Activity |
| 07/28/2011 | US20110182925 Ehrlichia canis DIVA (Differentiate Infected from Vaccinated Animals) |
| 07/28/2011 | US20110182924 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
| 07/28/2011 | US20110182923 Novel group b streptococcus antigens |
| 07/28/2011 | US20110182922 Peptides of il1 beta and tnf alpha and method of treatment using same |
| 07/28/2011 | US20110182921 Regulatory t cell epitopes, compositions and uses thereof |
| 07/28/2011 | US20110182919 Immunoglobulin Chimeric Monomer-Dimer Hybrids |